Veru Inc is currently not in a favorable trading position (SELL) according to technical analysis indicators. More on Technical Analysis. Peers. Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress. Veru Stock Smart Score ; Analyst Consensus. Moderate Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Neutral. VERU Sentiment 50% Sector. Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. Stock analysis for Veru Inc (VERU:NASDAQ CM) including stock price pharmaceuticals. Veru Inc. was founded in and is headquartered in Miami.
Price to Free Cash Flow, - ; Total Sales (TTM), M ; Revenue per Share (TTM), ; Shares Outstanding, M ; Share Float (%), M (%). Veru Inc.'s stock symbol is VERU and currently trades under NASDAQ. It's current price per share is approximately $ When is Veru Inc.'s next earnings date? Veru Inc VERU:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High I just received my proxy vote material about the increase in authorized shares of VERU. Big Pharma can most likely get faster approval with regulators. Veru Inc Share Price · 1 Day % · 1 Week + 5% · 1 Month % · 3 Months % · 6 Months + 68% · 1 Year % · 3 Year %. Veru Inc. ; Aug 28 Aug 30 ; ; 0 80k. Shares of Veru Inc. rocketed % toward a month high in afternoon trading Monday, after biopharmaceutical company announced positive results from its Phase. Veru market cap as of August 09, is $B. Compare VERU With Other Stocks FSD PHARMA (HUGE), Canada, $B, SNDL (SNDL), Canada, $B, Veru's trading volume is million.. View Veru Inc's Trading Volume trends, charts, and more. Get Veru Inc (VERU.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Track Veru Inc (VERU) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable.
Stock Information · Financial Information · SEC Filings · Annual Reports · IRS Form Back to totravelme.ru Continue. X. After submission, please check your. Stock Snapshot ; Market/Symbol. Nasdaq: VERU ; Price. ; Change. (%) ; Volume. k ; Day Range. - Veru has % upside potential, based on the analysts' average price target. Veru has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0. Veru Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VERU updated stock price target summary Pharma · Wellness. More. Your. Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates. Veru (VERU) delivered earnings and revenue surprises of % and %, respectively. I have a sneaky suspicion that VERU has cancelled the Sales Agreement to sell shares on the open market due to an impending deal with a Big Pharma or. Buy. Share Information ; Year High. ; Year Low. ; Exchange. NCM ; Shares Out. m ; Marketcap. m. Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS. Veru Inc. ; , ; , ; , ; ,
VERU INC. VERU | stock. $ %. $ M. %. $ -. Overview Amryt Pharma Plc - ADR. $ -$ %. Allstar Health Brands Inc. $ Exchange. NASDAQ-CM ; Sector. Health Care ; Industry. Biotechnology: Pharmaceutical Preparations ; 1 Year Target. $ ; Today's High/Low. $/$ According to the 4 analysts' twelve-month price targets for Veru, the average price target is $ The highest price target for VERU is $ Veru Shares Outstanding | VERU ; Oramed Pharmaceuticals (ORMP), United States, $B ; InterCure (INCR), Israel, $B ; Cellectar Biosciences (CLRB). Stock Information · Financial Information · SEC Filings · Annual Reports · IRS Form You are now leaving totravelme.ru Back to totravelme.ru Continue. X.
The Veru share price today is The stock symbol (or 'ticker') for Veru Inc is "VERU." What Stock Exchange Does Veru Inc Trade On? Veru Inc is listed and. Veru is a biopharmaceutical company that focuses on infectious diseases and oncology. They develop novel medicines for COVID and other viral and ARDS-. Veru's earnings in is -$40,,On average, 5 Wall Street analysts forecast VERU's earnings for to be -$43,,, with the lowest VERU. Analysis · Stay Away From Veru Until · Veru: Great Potential Despite FDA Rejection Of Sabizabulin EUA · Veru: Down And Possibly Out After FDA Rejects COVID. Biography. Harry Fisch MD. Vice Chairman & Chief Corporate Officer. Harry Fisch founded Veru, Inc. and Aspen Park Pharmaceuticals, Inc. He is on the board.
How Learn Python Fast | Safelite 30 Off Promo Code